Angela Schumich

Vienna, Austria

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications

Flow-cytometric MRD detection in pediatric T-ALL: a multicenter AIEOP-BFM consensus-based guided standardized approach.

Flow-cytometric MRD detection in pediatric T-ALL: a multicenter AIEOP-BFM consensus-based guided standardized approach.

Journal: Clinical chemistry and laboratory medicine
Published: December 26, 2024

Erratum to: Genomic breakpoint-specific monitoring of measurable residual disease in pediatric non-standard risk acute myeloid leukemia.

Erratum to: Genomic breakpoint-specific monitoring of measurable residual disease in pediatric non-standard risk acute myeloid leukemia.

Journal: Haematologica
Published: July 01, 2024

Risk factors in DUX4-positive childhood and adolescent B-cell acute lymphoblastic leukemia.

Risk factors in DUX4-positive childhood and adolescent B-cell acute lymphoblastic leukemia.

Journal: Blood cancer journal
Published: May 07, 2024

CD371-positive pediatric B-cell acute lymphoblastic leukemia: propensity to lineage switch and slow early response to treatment.

CD371-positive pediatric B-cell acute lymphoblastic leukemia: propensity to lineage switch and slow early response to treatment.

Journal: Blood
Published: July 31, 2023

FCM marker importance for MRD assessment in T-cell acute lymphoblastic leukemia: An AIEOP-BFM-ALL-FLOW study group report.

FCM marker importance for MRD assessment in T-cell acute lymphoblastic leukemia: An AIEOP-BFM-ALL-FLOW study group report.

Journal: Cytometry. Part A : the journal of the International Society for Analytical Cytology
Published: November 21, 2022

Genomic breakpoint-specific monitoring of measurable residual disease in pediatric non-standard-risk acute myeloid leukemia.

Genomic breakpoint-specific monitoring of measurable residual disease in pediatric non-standard-risk acute myeloid leukemia.

Journal: Haematologica
Published: November 16, 2022

Automated identification of cell populations in flow cytometry data with transformers.

Automated identification of cell populations in flow cytometry data with transformers.

Journal: Computers in biology and medicine
Published: December 14, 2021

UMAP Based Anomaly Detection for Minimal Residual Disease Quantification within Acute Myeloid Leukemia.

UMAP Based Anomaly Detection for Minimal Residual Disease Quantification within Acute Myeloid Leukemia.

Journal: Cancers
Published: December 03, 2021

An Extensive Quality Control and Quality Assurance (QC/QA) Program Significantly Improves Inter-Laboratory Concordance Rates of Flow-Cytometric Minimal Residual Disease Assessment in Acute Lymphoblastic Leukemia: An I-BFM-FLOW-Network Report.

An Extensive Quality Control and Quality Assurance (QC/QA) Program Significantly Improves Inter-Laboratory Concordance Rates of Flow-Cytometric Minimal Residual Disease Assessment in Acute Lymphoblastic Leukemia: An I-BFM-FLOW-Network Report.

Journal: Cancers
Published: September 30, 2021

Expression Patterns of Coagulation Factor XIII Subunit A on Leukemic Lymphoblasts Correlate with Clinical Outcome and Genetic Subtypes in Childhood B-cell Progenitor Acute Lymphoblastic Leukemia.

Expression Patterns of Coagulation Factor XIII Subunit A on Leukemic Lymphoblasts Correlate with Clinical Outcome and Genetic Subtypes in Childhood B-cell Progenitor Acute Lymphoblastic Leukemia.

Journal: Cancers
Published: June 20, 2020

The hematopoietic stem cell marker VNN2 is associated with chemoresistance in pediatric B-cell precursor ALL.

The hematopoietic stem cell marker VNN2 is associated with chemoresistance in pediatric B-cell precursor ALL.

Journal: Blood advances
Published: September 06, 2019

Phospho-Profiling Linking Biology and Clinics in Pediatric Acute Myeloid Leukemia.

Phospho-Profiling Linking Biology and Clinics in Pediatric Acute Myeloid Leukemia.

Journal: HemaSphere
Published: June 27, 2019
Showing 1-12 of 19

Last Updated: 09/26/2026